Close X
Saturday, November 30, 2024
ADVT 
International

Omicron causing hospitalisations, deaths worldwide: WHO

Darpan News Desk IANS, 19 Jan, 2022 12:45 PM
  • Omicron causing hospitalisations, deaths worldwide: WHO

New Delhi, Jan 19 (IANS) In a fresh warning, WHO chief Tedros Adhanom Ghebreyesus has said that Omicron variant of the coronavirus is causing hospitalisations and deaths the world over, and the narrative that it is a mild disease is misleading.

Amid an ongoing resurgence across the world, the global coronavirus caseload has topped 333.5 million, while the deaths have surged to more than 5.55 million and vaccinations to over 9.68 billion, according to Johns Hopkins University.

"Make no mistake, Omicron is causing hospitalisations and deaths, and even the less severe cases are inundating health facilities," the WHO chief said late on Tuesday.

"Omicron may be less severe, on average, but the narrative that it is a mild disease is misleading, hurts the overall response and costs more lives," he added.

India on Wednesday reported 2,82,970 fresh Covid cases in the last 24 hours, which is a rise of over 18 per cent from the previous day's count.

According to Tedros, Covid is circulating far too intensely with many still vulnerable.

"For many countries, the next few weeks remain really critical for health systems. I urge everyone to do their best to reduce risk of infection so that you can help take pressure off the system," he emphasised.

Tedros said that we can still significantly reduce the impact of the current wave by sharing and using health tools effectively and implementing public health and social measures that we know work.

"Every variant of the COVID-19 virus, including Omicron, is dangerous and can cause: severe disease, death, further virus mutations and jeopardise the effectiveness of the tools we have to fight it," said the WHO.

 

 

 

MORE International ARTICLES

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK

UN: Europe's pandemic restrictions are absolutely necessary

UN: Europe's pandemic restrictions are absolutely necessary
In a meda briefing on Thursday, Dr. Hans Kluge warned that even more drastic steps might be needed in such “unprecedented times.”

UN: Europe's pandemic restrictions are absolutely necessary